De interés

16 sept. 2020

Mylan and Development Partner, Synthon, Win Significant EPO Ruling Related to Copaxone® 40mg/mL

Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe

más información
02 jul. 2019

BC Partners to Acquire Synthon International Holding B.V.

BC Partners to Acquire Synthon International Holding B.V., a Global Market Leader in the Development of Complex Generics

más información
05 oct. 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

Synthon today announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-filled syringe for the treatment of relapsing forms of multiple sclerosis…

más información
More news

Synthon en el mundo